Losoxantrone
Overview of the chemotherapeutic agent Losoxantrone
| Losoxantrone | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Overview[edit]
Losoxantrone is a synthetic antineoplastic agent belonging to the class of anthrapyrazoles. It is primarily used in the treatment of various types of cancer, including breast cancer, leukemia, and lymphoma. Losoxantrone functions by intercalating into DNA, thereby disrupting the replication of cancer cells and inhibiting their proliferation.
Mechanism of Action[edit]
Losoxantrone exerts its effects by intercalating into the DNA double helix. This intercalation disrupts the DNA replication process, leading to the inhibition of topoisomerase II, an enzyme crucial for DNA repair and replication. By inhibiting this enzyme, Losoxantrone prevents the cancer cells from dividing and proliferating, ultimately leading to cell death.
Pharmacokinetics[edit]
Losoxantrone is administered intravenously and is known for its rapid distribution throughout the body. It is metabolized primarily in the liver and excreted through the biliary system. The drug has a relatively long half-life, allowing for sustained action against cancer cells.
Clinical Use[edit]
Losoxantrone is used in the treatment of various malignancies, including:
The drug is often used in combination with other chemotherapeutic agents to enhance its efficacy.
Side Effects[edit]
Common side effects of Losoxantrone include:
- Nausea and vomiting
- Myelosuppression, leading to decreased white blood cell count
- Cardiotoxicity, which may manifest as congestive heart failure
- Alopecia
Patients receiving Losoxantrone require regular monitoring of their cardiac function and blood cell counts to manage these side effects effectively.
Research and Development[edit]
Ongoing research is focused on improving the efficacy and safety profile of Losoxantrone. Studies are exploring its use in combination with novel agents and its potential role in treating other types of cancer.
Related pages[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
